Music in Vein in the Intensive Care Unit
1 other identifier
interventional
200
1 country
1
Brief Summary
Patients admitted to the Intensive Care Units (ICU) that receive mechanical ventilation need high dose sedative and analgesic medication that may have side effects. Despite this, many of them also experience anxiety and added stress. Musical intervention is a useful non-pharmacological tool without adverse effects safe and easy to provide for patients with mechanical ventilation admitted to the Intensive Care Units. Its use reduces the use and dose of sedatives, reduces stress and environmental noise. It should be considered in the measures of control of anxiety and noise in the ICU. The objective of the study is to analyze whether the implementation of a musical intervention can be an effective non-pharmacological intervention in the therapy of patients undergoing mechanical ventilation admitted to an Intensive Care Unit of a High Complexity Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 19, 2020
CompletedFirst Posted
Study publicly available on registry
March 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFebruary 10, 2021
February 1, 2021
4.4 years
February 19, 2020
February 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total and extra pseudoanalgesia requirements change.
Change of the anxiety and pain level in patients with invasive mechanical ventilation with music therapy.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary Outcomes (9)
Change of Heart rate.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Change of systolic blood pressure; diastolic blood pressure and mean blood pressure.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Change vasoactive drug requirements.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Blood glucose control.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Change insulin requirements.
It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
- +4 more secondary outcomes
Study Arms (2)
Intervention group in which musical intervention
EXPERIMENTALGroup A: Experimental group in which musical intervention will be applied between the first and the third day of mechanical ventilation.
Control group
OTHERGroup B: Control group with standard treatment without musical intervention.
Interventions
Intervention group in which musical intervention will be applied the first or third day of mechanical ventilation.
Control group with standard treatment without musical intervention.
Eligibility Criteria
You may qualify if:
- Adult patients admitted to the ICU with requirements for mechanical ventilation and in which the unit's pseudoanalgesia protocol is implemented.
- A legal representative informed consent to participate in the study has to be signed.
You may not qualify if:
- Patients admitted to the ICU with predictable survival less than 48 hours.
- Patients who are not subjected to mechanical ventilation.
- Patients whose Legal representative refuses to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Juan Carlos Montejo, PhD MD
Hospital Universitario 12 de Octubre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Intensive Care Medicine Service, MD, PhD
Study Record Dates
First Submitted
February 19, 2020
First Posted
March 2, 2020
Study Start
January 1, 2017
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
February 10, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share